| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.0037 | 1 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.0029 | 1 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |